Literature DB >> 31526521

Ranibizumab and Aflibercept Levels in Breast Milk after Intravitreal Injection.

Verena R Juncal1, Quratulain Paracha2, Motaz Bamakrid2, Carolina L M Francisconi1, Julia Farah3, Amin Kherani4, Rajeev H Muni5.   

Abstract

Entities:  

Year:  2019        PMID： 31526521     DOI： 10.1016/j.ophtha.2019.08.022

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  2 in total

1.  [Anti-VEGF (anti-vascular endothelial growth factor) treatment for central vein occlusion during breastfeeding].

Authors:  S Groselli; L Bechstein; K Gabka; M Ulbig
Journal:  Ophthalmologie       Date:  2022-07-20

2.  Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report.

Authors:  Ying Huang; Rong Zhou; Zuhua Sun; Yihan Zheng; Bing Lin
Journal:  Int Breastfeed J       Date:  2022-03-31       Impact factor: 3.461
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.